Abstract:OBJECTIVE:To explore the association between hypoxia-inducible factor 1α (HIF-1α) expression and lymph node metastasis in oral squamous cell carcinoma (OSCC).METHODS:Tumor specimens from 125 patients with histologically-proven, surgically-treated OSCC were examined by immunohistochemical staining for expression of HIF-1α. The patients were divided into two groups by the expression of HIF-1α, high expression of HIF -1α group (H-group) and low expression of HIF-1α group (L-group). The main assessment parameters were lymph node metastasis rate and disease-specific survival (DSS). The lymph node metastasis rate and clinicopathologic features were compared using Mann-Whitney test. The Kaplan-Meier curve was generated for each group and compared using the log-rank test. Cox proportional hazard models were utilized for multivariate analyses of HIF-1α expression and other baseline factors with DSS. All calculations and analyses were performed using the SPSS 17.0 software package.RESULTS:The protein expression levels of HIF-1α were up-regulated in OSCC and two patients were unable to evaluate. There were 48 patients in L-group and 75 patients in H-group. Lymph node metastasis rate was 37.5% (18/48) for L-group and 58.7% (44/75) for H-group (P=0.027). Expression of HIF-1α was significantly correlated with lymph node metastasis. The patients of L-group had a significantly better DSS than the patients of H-group (70.8% vs. 46.7%, P=0.005), while the patients of L-group had a significantly better disease-free survival (DFS) than the patients of H-group (60.4% vs. 36.0%, P=0.009) by Kaplan-Meier method. A multivariate survival analysis also showed that HIF-1α expression (HR=2.164, 95%CI: 1.150-4.074, P=0.017) and T-stage (HR=1.387, 95%CI: 1.066-1.804, P=0.015) both were the independent factors associated with prognosis.CONCLUSION:HIF-1α expression is significantly correlated with lymph node metastasis in OSCC. HIF-1α expression is an independent predictive factor for prognosis of OSCC patients, and may serve as a potential biomarker for molecular diagnosis and targeted therapy in future.

Increased Expression of FOXD1 is Associated with Cervical Node Metastasis and Unfavorable Prognosis in Oral Squamous Cell Carcinoma

Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC

The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma.

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma

Dysregulation of FOXD2-AS1 Promotes Cell Proliferation and Migration and Predicts Poor Prognosis in Oral Squamous Cell Carcinoma: a Study Based on TCGA Data.

Foxp3 Overexpression in Tumor Cells Predicts Poor Survival in Oral Squamous Cell Carcinoma

FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2

The Expression and Survival Significance of FOXD1 in Lung Squamous Cell Carcinoma: A Meta-Analysis, Immunohistochemistry Validation, and Bioinformatics Analysis

DDX59-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in OSCC.

Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis

CXCL12 is Associated with FoxP3+ Tumor-Infiltrating Lymphocytes and Affects the Survival of Patients with Oral Squamous Cell Carcinoma.

Forkhead Box N1 is Possibly a Novel Biomarker and Prognostic Indicator for Patients with Squamous Cell Lung Carcinoma

Expression of Tumor Suppressor SFRP1 Predicts Biological Behaviors and Prognosis: A Potential Target for Oral Squamous Cell Carcinoma

[Expression of Hypoxia-Inducible Factor 1α is Associated with Lymph Node Metastasis in Oral Squamous Cell Carcinoma].

Contribution of Foxc1 to the Progression and Metastasis and Prognosis of Human Colon Cancer.

Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis

Correlation Between Expression of Forkhead Box M1 (FOXM1) and Clinicopathological Features and Prognosis in Patients with Non-Small Cell Lung Cancer (NSCLC)

Expression and Prognostic Value of FOXP1 in Esophageal Squamous Cell Carcinoma.

Overexpression of FOXM1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation, Migration and Invasion in Epithelial Ovarian Cancer.

Foxm1 Is Associated With Poor Prognosis Of Non-Small Cell Lung Cancer Patients Through Promoting Tumor Metastasis

Forkhead Box D1 Promotes EMT and Chemoresistance by Upregulating Lncrna CYTOR in Oral Squamous Cell Carcinoma